Loading company filing…
Find a company. Follow its revenue through costs and profit.
Coverage includes separate ticker and security records; counts are not unique companies.
Sankey diagram of Stryker Corporation. A complete text table follows the diagram.
Nine medical-technology franchises create a balanced $6.0 billion sales mix, with faster vascular and trauma growth offsetting the disposal-driven collapse in spinal implants
Swipe to explore
Ortho Tech & Spine combines directly reported $646M Ortho Tech and $2M Spinal Implants sales. All other flows are directly reported.
Labels and narrative explain the filing. A category marked “arithmetic bridge” or “residual” is calculated from reported totals, rather than a separately reported line.
| Category | Stage | Value | Notes |
|---|---|---|---|
| Instruments | 1 | $920M | Surgical equipment · +9.8% |
| Endoscopy | 1 | $868M | Visualization and minimally invasive care |
| Medical | 1 | $902M | Beds, emergency and acute care |
| Vascular | 1 | $517M | Fastest-growing franchise · +27.3% |
| Knees | 1 | $670M | Joint replacement |
| Hips | 1 | $460M | Joint replacement |
| Trauma & Extremities | 1 | $1.0B | Largest franchise · +9.5% |
| Ortho Tech & Spine | 1 | $648M | Enabling technology and remaining spine |
| Net sales | 2 | $6.0B | 2.6% reported growth |
| Gross profit | 3 | $3.8B | 63.3% gross margin |
| Cost of sales | 3 | $2.2B | Manufacturing and supply chain |
| Operating income | 4 | $936M | 15.5% reported margin |
| R&D and engineering | 4 | $413M | Product innovation |
| Selling, general & administrative | 4 | $2.3B | Commercial and operating footprint |
| Intangible amortization | 4 | $180M | Acquired technology |
| Other income | 4 | $62M | Non-operating income |
| Earnings before tax | 5 | $850M | 14.1% of sales |
| Interest expense | 5 | $148M | Acquisition and corporate debt |
| Net earnings | 6 | $745M | $1.93 diluted EPS |
| Income tax | 6 | $105M | 12.4% effective rate |
| From | To | Value |
|---|---|---|
| Instruments | Net sales | $920M |
| Endoscopy | Net sales | $868M |
| Medical | Net sales | $902M |
| Vascular | Net sales | $517M |
| Knees | Net sales | $670M |
| Hips | Net sales | $460M |
| Trauma & Extremities | Net sales | $1.0B |
| Ortho Tech & Spine | Net sales | $648M |
| Net sales | Gross profit | $3.8B |
| Net sales | Cost of sales | $2.2B |
| Gross profit | Operating income | $936M |
| Gross profit | R&D and engineering | $413M |
| Gross profit | Selling, general & administrative | $2.3B |
| Gross profit | Intangible amortization | $180M |
| Operating income | Earnings before tax | $788M |
| Operating income | Interest expense | $148M |
| Other income | Earnings before tax | $62M |
| Earnings before tax | Net earnings | $745M |
| Earnings before tax | Income tax | $105M |